Eton Pharmaceuticals, Inc.

8-K Entered a material agreement; Completed an acquisition or disposition Aug 5, 2026 8-K Director or officer change Aug 4, 2026 8-K Other events Jul 29, 2026 8-K Shareholder vote results Jun 9, 2026 8-K Entered a material agreement; Completed an acquisition or disposition May 19, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Other events May 1, 2026 8-K Other events Apr 27, 2026 8-K Director or officer change; Regulation FD disclosure Apr 16, 2026 8-K Entered a material agreement; Took on a direct financial obligation Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Entered a material agreement; Completed an acquisition or disposition Mar 2, 2026 8-K Other events Feb 25, 2026 8-K Other events Feb 2, 2026 8-K Regulation FD disclosure Dec 4, 2025 8-K/A Completed an acquisition or disposition Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Jul 8, 2025 8-K Other events Jun 27, 2025 8-K Changed accountants Jun 20, 2025 8-K Shareholder vote results Jun 10, 2025 8-K Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K/A Completed an acquisition or disposition; Other events May 2, 2025 8-K Other events Apr 28, 2025 8-K Other events Apr 1, 2025 8-K Regulation FD disclosure Mar 18, 2025 8-K Results of operations (earnings release) Mar 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Other events Mar 14, 2025 8-K/A Completed an acquisition or disposition; Other events Mar 7, 2025 8-K Other events Mar 3, 2025 8-K Other events Feb 7, 2025 8-K Other events Feb 6, 2025